Search Results
May 28, 2026, 12:09 ET Baha Mar and Colin Cowie Introduce the Baha Mar Celebration Collection, Designed by Colin Cowie, A New Standard for Destination Weddings
taste transforms spaces into masterpieces. By blending the natural beauty of The Bahamas with his boundless creativity, we are offering couples the rare opportunity to realize the wedding of their dreams—expertly designed by Colin himself, where every detail is considered and every moment is elevated."The
More news about: Baha Mar
May 28, 2026, 11:00 ET TRUE GLOBAL VENTURES APPOINTS TAL ELYASHIV AS GENERAL PARTNER
entrepreneur, venture capitalist and technology executive with a distinguished career spanning Silicon Valley, Wall Street and Tel Aviv, Elyashiv brings a rare combination of deep-tech investing expertise, experience as an operator and institutional finance leadership to the firm. He will be relocating to the
More news about: True Global Ventures
May 28, 2026, 10:59 ET Friends & Neighbors | F&N Med Names Dan Hoedeman Managing Director
brands navigating complexity and sees MedTech as the exact territory where belief-driven thinking shifts the status quo. "Friends & Neighbors has a rare ability to blend strategic sharpness with soulful creative and turn that into real business impact," he said. "I'm excited to help write the next chapter,
More news about: Friends & Neighbors
May 28, 2026, 10:22 ET Associated Bank Returns as Title Sponsor of Second Annual Audaxity Bike Ride, Driving Community Impact for Local Cancer Research
With 100% of funds raised staying local, the event plays a meaningful role in advancing research that is improving outcomes for adult, pediatric and rare cancer patients across the region and the country."Returning as the title sponsor of Audaxity reflects our deep commitment to the communities
More news about: Associated Banc-Corp
May 28, 2026, 10:00 ET Reactor Emerges from Stealth with $59M to Build the Platform for Real-Time AI Worlds
developers due to a lack of infrastructure that can reliably serve them," said Bucky Moore, Partner at Lightspeed. "Alberto, Bryce, and the team bring a rare combination of real-time systems expertise and product vision to this problem, and we believe Reactor is well positioned to become the foundational
More news about: Reactor
May 28, 2026, 10:00 ET Reactor Emerges from Stealth with $59M to Build the Platform for Real-Time AI Worlds
developers due to a lack of infrastructure that can reliably serve them," said Bucky Moore, Partner at Lightspeed. "Alberto, Bryce, and the team bring a rare combination of real-time systems expertise and product vision to this problem, and we believe Reactor is well positioned to become the foundational
More news about: Reactor
May 28, 2026, 10:00 ET Reactor sort de sa phase furtive avec un financement de 59 millions de dollars pour construire la plateforme des modèles mondiaux d'IA en temps réel
d'infrastructure capable de les servir de manière fiable », déclare Bucky Moore, partner, Lightspeed. « Alberto, Bryce et l'équipe apportent une combinaison rare d'expertise en systèmes temps réel et de vision du produit à ce problème, et nous pensons que Reactor est bien placé pour devenir la plateforme de base
More news about: Reactor
May 28, 2026, 09:45 ET The Rare Earth Race Has a New Front-Runner
isn't just another rare earths venue. It's a heavy rare earth behemoth, while most global deposits focus on less valuable light rare earth production. Critical Metals estimates heavy rare earths account
More news about: OilPrice.com
May 28, 2026, 09:15 ET Lunai Bioworks and BrainStorm Therapeutics Launch Foundation-Funded Parkinson's and Rare Epilepsy AI Discovery Collaboration
improve human translational relevance and reduce dependence on traditional mammalian animal models in drug development. Initial efforts will focus on rare genetic epilepsies and neurodegenerative diseases, including Parkinson's disease.As part of the collaboration, the companies are integrating
More news about: Lunai Bioworks Inc.
May 28, 2026, 09:15 ET Anti-Aging Cell Therapy Reaches Major GMP Milestone as Wave of Clinical Advancements Gain Momentum
Cell-in-a-Box® cell-encapsulation intellectual property and GMP manufacturing capability creates an integrated development-to-clinic structure rare among small-cap longevity-focused biotech.Chris Winter, Chief Executive Officer of Avaí Bio, framed the program direction in the Company's release,
More news about: USA News Group
May 28, 2026, 09:07 ET Volara Motorsports Group Acquires Lynx Motor Works, Strengthening Premium Automotive Portfolio
character."Lynx Motor Works represents exactly the kind of brand we seek — one with an authentic identity, a differentiated product roadmap, and a genuinely rare customer relationship. We are proud to be its steward." — Christian Okonsky, Founder and CEO, Volara Motorsports GroupLynx Motor Works
More news about: Volara Motorsports Group
May 28, 2026, 09:01 ET Atlanta's 19th Street Dental Marks Approaching 20th Anniversary with Summer Whitening Promotion as City Hosts International Soccer Spotlight
the result. A video testimonial featuring Steven's story is available upon media request."The international soccer tournament is one of those rare moments that brings global attention to our city," said Dr. Patel. "Atlanta is on the world stage, and we are incredibly proud to be part of this community.
More news about: 19th Street Dental
May 28, 2026, 09:00 ET GeneDx Holdings (WGS) 49% Drop Triggers Investor Scrutiny Over Disconnect From Prior Growth Narrative- HBSS
844-916-0895GeneDx Holdings Corp. (WGS) Investigation: GeneDx operates a data-driven clinical diagnostics business model focused on rare and ultra-rare disease testing emphasizing its whole genome sequencing and whole exome sequencing tests as primary growth drivers.The company derives
More news about: Hagens Berman Sobol Shapiro LLP
May 28, 2026, 09:00 ET Zydus Therapeutics New Drug Application (NDA) for Saroglitazar to Treat Primary Biliary Cholangitis (PBC) Granted Priority Review by the US FDA
tract infection, abdominal pain, COVID-19, diarrhea, and vitamin D deficiency.About Primary Biliary Cholangitis (PBC):PBC is a rare, progressive autoimmune disease that gradually destroys the bile ducts, resulting in an accumulation of bile in the liver, which can result in fibrosis,
More news about: Zydus Therapeutics, Inc.
May 28, 2026, 09:00 ET Northwind Group Announces $300M Institutional Capital Partnership with ATLAS SP Partners to Deliver Lower Cost of Capital Across Credit Platform
caliber allows us to offer borrowers flexible and friendly financing solutions with high certainty of execution. In today's market, that combination is rare, and we believe it positions NDF III to further execute on our business plan.""We are pleased to partner with Northwind and help facilitate their
More news about: Northwind Group
May 28, 2026, 09:00 ET Aokah Compresses Fortune 500 GCC Site Selection From 10 Weeks to Less Than One Week, Earns HFS Hot Tech Designation for AI-Native Services-as-Software Model
Research names Aokah an early leader in shifting GCC advisory from weeks-long consulting cycles to AI-led, hours-long decision intelligence, citing a rare live enterprise proof point and the only pure-play GCC Services-as-Software platform in the marketNEW YORK,
More news about: Aokah Inc
May 28, 2026, 08:54 ET Florida Cancer Specialists & Research Institute Advances the Future of Cancer Care
research efforts, we are generating new scientific insights that are advancing precision oncology for patients with a wide range of cancers, including rare and advanced disease."The following FCS principal investigators are first authors on ten abstracts that will be presented throughout the meeting:
More news about: Florida Cancer Specialists & Research Institute
May 28, 2026, 08:30 ET Strengthen Participant-Site Readiness for Complex Rare Disease Trials, Upcoming Webinar Hosted by Xtalks
In this free webinar, see perspectives on the impact of rising clinical trial complexity across all stakeholders, especially in Rare Disease. Attendees will learn about designing trials with and for sites and patients. The featured speakers will discuss how to retain participants in clinical trials
More news about: Xtalks
May 28, 2026, 08:29 ET Trusted by Leading Cancer Centers to Solve Oncology's Information Overload, Triomics Raises $22 million to Accelerate Adoption
infrastructure already powers multiple distinct workflows with no redundant integrations. That kind of platform leverage, inside a customer base this strong, is rare at this stage."About TriomicsTriomics is an oncology AI company building the infrastructure that turns complex, longitudinal
More news about: Triomics
May 28, 2026, 08:05 ET INOVIO to Participate in Upcoming Scientific and Investor Conferences
https://event.summitcast.com/view/NgCqua4VVQjq9ibVWHVWca/adRiTkvKf4AnDsZYyXatz8 World Orphan Drug Congress (Boston) Poster Presentation: Rare Disease Protein Replacement Therapeutics: The Transformational Potential of Next-Gen DNA Medicine Date: Thursday, June 11 Time:
More news about: INOVIO Pharmaceuticals, Inc.
May 28, 2026, 06:10 ET Brandi AI Named G2 Summer 2026 High Performer for Answer Engine Optimization
benchmark that measures how likely customers are to recommend a company, product or service. Because NPS ranges from -100 to +100, a perfect score is rare and means every surveyed Brandi AI customer was a promoter, with no passive or dissatisfied respondents. For Brandi AI, that result signals exceptional
More news about: Brandi AI
May 27, 2026, 18:18 ET U.S. FDA Approves DECNUPAZ™ (pivekimab sunirine-pvzy) for Treatment of Adult Patients With Blastic Plasmacytoid Dendritic Cell Neoplasm, an Ultra-Rare and Aggressive Blood Cancer With Limited Treatment Options
with BPDCN, an ultra-rare and aggressive hematologic malignancy with limited treatment options. The approval is supported by data from the Phase 1/2 CADENZA trial, a global study evaluating the safety and efficacy of DECNUPAZ for BPDCN. "For patients living with rare cancers, progress in
More news about: AbbVie
May 27, 2026, 17:00 ET Phase 3 HERIZON-GEA-01 Results Published in The New England Journal of Medicine Show Durable and Consistent Survival Benefit with Ziihera® (zanidatamab-hrii) Combinations in First-Line HER2+ Locally Advanced or Metastatic GEA
purpose is to innovate to transform the lives of patients and their families. We are dedicated to developing life-changing medicines for people with rare disease — often with limited or no therapeutic options. We have a diverse portfolio of medicines, including leading therapies addressing epilepsies,
More news about: Jazz Pharmaceuticals plc
May 27, 2026, 16:30 ET Azitra Announces Intention to Adjourn Annual Meeting and Reconvene Annual Meeting
precision dermatology. The Company's lead program, ATR-12, uses an engineered strain of S. epidermidis designed to treat Netherton syndrome, a rare, chronic skin disease with no approved treatment options. Netherton syndrome may be fatal in infancy with those living beyond a year having profound
More news about: Azitra, Inc.
May 27, 2026, 13:47 ET Kellogg School of Management Expands Executive Education Programs to Meet Global Demand
residential, classroom, and collaborative spaces."When the Ann McIlrath Drake Executive Center opens, it will offer executives something genuinely rare—an immersive environment where they can step away from daily demands and focus on growing as leaders," Cohen said. "Experiences like this don't just
More news about: Kellogg School of Management